I need some sales if I'm going to stay in business.  Please place orders via the affiliate links on this web site.  It's the same price.  If you bookmark or type in the URL, I don't get credit for the sale.  The easiest way is just to bookmark any of my web pages and order from that.  If the links don't work, it could be your spyware.  I recommend Microsoft Windows DefenderClick here to address concerns about using credit cards via the Internet.
QualityCounts.com
   Comprehensive Anti-aging Research
Home iHerb Vitacost Int Antiaging Sys Prescriptions Life Extension Products drugstore.com Body Wise Contact
 Newsletter Archive
 Signup for Newsletter
 Newsletter via RSS Feed
 Anti-aging Research
 Health Conditions
 Anti-aging Recommendations
 Insulin and Aging
 QualityCounts.com in Time
 Longevity Web Sites
 Drug Databases
 Longevity Affiliates:
 Complete Shopping Directory
 iHerb
 Int. Anti-aging Systems
 Life Extension Products
 Vitacost
 Puritan's Pride
 Vitamin Shoppe
 Vonage
 Amazon.com
 Medifast Diet
 Dual Action Cleanse!
 DrugStore.com, Inc.
 GNC via drugstore.com
 JandR.com
 The Sharper Image
 Beauty.com
 Revival Soy Products
 Dr. Weil's Polaris productsicon
 Dr. Atkins Productsicon
 Vital Choice Seafood
 Road Runner Sports
 Online Prescriptions
 Love Scent Pheromones
 DERMAdoctor.com
 Youthful Essence
 Principal Secret
 Winsor Pilates
 Natural Advantage
 GreatSkin.com
 Blood Test Order Forms
 Overseas Pharmacies

Welcome to the Quality Counts. For those health conscious consumers and medical professionals that are looking to purchase nutritional supplements, vitamins, herbs, learning about medications, losing weight, health food, low carbs, high protein nutrition, and exercise, you have come to the right place. Quality Counts serves both the medical practitioner and consumer interested in nutritional therapy and alternative medicine.

Home > Anti-aging Research > B Vitamins.

B Vitamins

Specific Recommendations:

CME/CEM:

General Information:

Other News:

Abstracts:

  • Effect of Coenzyme Q(10), Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles - Breast Cancer Res Treat. 2008 Apr 22 - "Tamoxifen (TAM) ... TAM also has estrogenic activity on liver and endometrium causing severe oxidative stress with various biochemical derangements. Coenzyme Q(10), Riboflavin and Niacin (CoRN) are well-known potent antioxidants and protective agents against many diseases including cancer ... A statistically significant alteration in various blood chemistry parameters, such as serum total bilirubin (S. BIL), serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), gamma glutamyl transpeptidase (gamma-GT), uric acid (UA), lipoprotein lipase (LPL), lecithin: cholesterol acyl transferases (LCAT), potassium, calcium and Na(+), K(+)-ATPase in sole TAM-treated group, was favorably reverted back to near normal levels on combinatorial therapy with CoRN" - See coenzyme Q10 products at iHerb.
  • Folate and MTHFR: risk of adenoma recurrence in the Polyp Prevention Trial - Cancer Causes Control. 2008 Mar 6 - "Low dietary folate intake has been associated with colorectal cancer risk and adenoma recurrence. A C/T transition at position 677 in the gene encoding methlylenetetrahydrofolate reductase (MTHFR C677T) has been reported to interact with folate intake to modulate colorectal adenoma recurrence or cancer risk ... In general, no statistically significant associations were found between quartile of folate intake (dietary or total) and adenoma recurrence ... No significant interaction was noted for total folate and MTHFR genotype, though an increased risk of recurrence noted for the MTHFR CT genotype was statistically significant only for those individuals with below median intake of total folate"
  • Is folic acid good for everyone? - Am J Clin Nutr. 2008 Mar;87(3):517-33 - "Folate has a dual effect on cancer, protecting against cancer initiation but facilitating progression and growth of preneoplastic cells and subclinical cancers"
  • Hepatoprotective effect of vitamin b(12) on dimethylnitrosamine-induced liver injury - Biol Pharm Bull. 2008 Feb;31(2):309-11 - "Vitamin B(12) decreased the blood levels of aspartate aminotransferase and alanine aminotransferase, and clearly inhibited the overaccumulation of collagen fibrils ... vitamin B(12) could be an effective hepatoprotective agent" - Note:  Aspartate aminotransferase is the AST reading on blood tests and alanine aminotransferase is the ALT.
  • Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease - Acta Cardiol. 2007 Dec;62(6):579-85 - "either folic acid 5 mg or NAC 600 mg or placebo daily for eight weeks ... endothelium-dependent dilation (EDD) ... Folic acid and NAC therapies decreased plasma homocysteine (from 21.7 +/- 8.7 micromol/l to 12.5 +/- 2.5 micromol/l, P < 0.001; from 20.9 +/- 7.6 micromol/l to 15.6 +/- 4.3 micromol/l, P = 0.03, respectively), and increased EDD (6.7 +/- 6.1% P = 0.002, 4.4 +/- 2.6% P < 0.001, respectively) compared with placebo. There was no significant difference in improving EDD between the folic acid and the NAC group"
  • Dietary vitamin b6 intake and the risk of colorectal cancer - Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):171-82 - "Moderately strong inverse and dose-dependent associations in the whole sample were found between CRC risk and the intake of dietary and total vitamin B6 in all three models [model III: odds ratio (OR), 0.77; 95% confidence interval (95% CI), 0.61-0.98; P for trend = 0.03; OR, 0.86; 95% CI, 0.69-1.07; P for trend = 0.12]. In addition, meta-analyses of published studies showed inverse associations between vitamin B6 and CRC (combined relative risk, 0.81; 95% CI, 0.68-0.96; test for overall effect P = 0.01; combined odds ratio, 0.67; 95% CI, 0.60-0.75; test for overall effect P < 0.00001)"
  • Folic acid supplementation in early second trimester and the risk of preeclampsia - Am J Obstet Gynecol. 2008 Jan;198(1):45.e1-7 - "Supplementation of multivitamins containing folic acid was associated with increased serum folate (on average 10.51 micromol/L), decreased plasma homocysteine (on average 0.39 micromol/L), and reduced risk of preeclampsia (adjusted odds ratio, 0.37; 95% confidence interval, 0.18-0.75)" - See iHerb folic acid products.
  • Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study - J Clin Psychiatry. 2007 Nov;68(11):1648-54 - "The mean decrease in ESRS clinical global impression scores from baseline to endpoint was 2.4 points in patients treated with vitamin B(6) and 0.2 points in patients treated with placebo (p < .0001). The mean decrease in the parkinsonism subscale score was 18.5 points and 1.4 points, respectively (p < .00001), and the mean decrease in the dyskinesia subscale score was 5.2 points and -0.8 points, respectively ... Vitamin B(6) appears to be effective in reducing symptoms of TD. The specific mechanisms by which vitamin B(6) attenuates symptoms of TD are not clear"
  • Association of folate intake with the occurrence of depressive episodes in middle-aged French men and women - Br J Nutr. 2007 Dec 6;:1-5 - "the risk of experiencing recurrent depressive episodes (two or more) during the follow-up was strongly reduced in men with high folate intake (OR 0.25 (95 % CI 0.06, 0.98) for the highest tertile v. the lowest" - See iHerb folic acid products.
  • Low vitamin B-12 status and risk of cognitive decline in older adults - Am J Clin Nutr. 2007 Nov;86(5):1384-91 - "concentrations of holoTC (a marker of reduced vitamin B-12 status), tHcy, and MMA predicted cognitive decline, but folate did not. A doubling in holoTC concentrations (from 50 to 100 pmol/L) was associated with a 30% slower rate of cognitive decline (-0.137 to -0.083), whereas a doubling in tHcy (from 10 to 20 mumol/L) or MMA (from 0.25 to 0.50 mumol/L) was associated with >50% more rapid cognitive decline (-0.090 to -0.169) and (-0.104 to -0.169), respectively" - See iHerb vitamin B12 products.
  • Low vitamin B-12 status and risk of cognitive decline in older adults - Am J Clin Nutr. 2007 Nov;86(5):1384-91 - "Low vitamin B-12 status was associated with more rapid cognitive decline"
  • Homocysteine, vitamins, and vascular disease prevention - Am J Clin Nutr. 2007 Nov;86(5):1563S-8S - "Dietary deficiency of vitamin B-6 and folic acid and absorptive deficiency of vitamin B-12, which result from traditional food processing or abnormal absorption of B vitamins, are important factors in causing elevations in blood homocysteine. Numerous clinical and epidemiologic studies have established elevated blood homocysteine as a potent independent risk factor for vascular disease in the general population. Dietary improvement, providing abundant vitamin B-6, folic acid, and cobalamin, may prevent vascular disease by lowering blood homocysteine. The dramatic decline in cardiovascular mortality in the United States since 1950 may possibly be attributable in part to voluntary fortification of the food supply with vitamin B-6 and folic acid. Fortification of the US food supply with folic acid in 1998, as mandated by the US Food and Drug Administration, was associated with a further decline in mortality from vascular disease, presumably because of increased blood folate and decreased blood homocysteine in the population"
  • Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels - Atherosclerosis. 2007 Oct 16 - "Retinal vein occlusion (RVO) is one of the most common retinal vascular disorders ... Blood levels of vitamin B6, folate and Hcy, but not of vitamin B12, were found to be significantly different in patients as compared to healthy subjects. At the univariate analysis, the lowest tertile of vitamin B6 [odds ratio (OR) 4.03; 95% confidence interval (CI) 2.58-6.31; P<0.0001)] and folate (OR 6.13; 95% CI 3.85-9.76, P<0.0001), and the highest tertile of Hcy (OR 8.08; 95% CI 5.05-12.92, P<0.0001) were found to be significantly associated with RVO. Moreover, at multivariate analysis, after adjustment for traditional cardiovascular risk factors, Hcy, and circulating levels of vitamins, respectively, the lowest tertile of vitamin B6 (OR 3.29; 95% CI 1.89-5.70, P<0.0001) and folate (OR 5.41; 95% CI 3.08-9.51, P<0.0001) and the highest tertile of Hcy (OR 2.58; 95% CI 1.12-5.94, P<0.0001) maintained their significant association with RVO"
  • Augmenting antidepressants with folate: a clinical perspective - J Clin Psychiatry. 2007;68 Suppl 10:4-7 - "Folate in particular has been found to further reduce symptoms in patients with depression when used in conjunction with an antidepressant, and because folate is a water-soluble B vitamin, its safety and tolerability are well established. This strategy would typically be used in patients with low plasma or red blood cell folate levels. Folate augmentation may be used (1) to enhance the efficacy of antidepressants in nonresponders, (2) to enable those who partially respond to antidepressant monotherapy to achieve remission, and (3) to alleviate residual symptoms during antidepressant treatment" - See iHerb folic acid products.
  • The role of folate in depression and dementia - J Clin Psychiatry. 2007;68 Suppl 10:28-33 - "folate deficiencies may be caused by improper absorption and utilization, often due to genetic polymorphisms. Individuals, therefore, can have insufficient levels or lack needed forms of folate, despite adequate intake. Supplementation with the active form of folate, methyltetrahydrofolate, which is more readily absorbed, may be effective in the prevention and treatment of both depression and dementia" - iHerb folic acid products.
  • B Vitamin Plasma Levels and the Risk of Ischemic Stroke and Transient Ischemic Attack in a German Cohort - Stroke. 2007 Sep 20 - "Our data suggest that low vitamin B12 plasma levels, particularly in combination with low folate levels, increase the risk of cerebral ischemia. This effect may be mediated at least partly through elevations of homocysteine levels"
  • Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn's disease - Inflamm Bowel Dis. 2007 Sep 20 - "Vitamin B(12) abnormalities are common in patients with CD and patients with a prior ileal or ileocolonic resection are at particular risk" - See iHerb Vitamin B12 products.
  • Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders - Fortschr Neurol Psychiatr. 2007 Sep;75(9):e1-e18 - "Elevated concentration of total homocysteine (Hcy) in plasma (> 12 micromol/l) is a risk factor for several diseases of the central nervous system. Epidemiological studies have shown a dose-dependent relationship between concentrations of Hcy and the risk for neurodegenerative diseases. Hcy is a marker for B-vitamin deficiency (folate, B (12), B (6)). Hyperhomocysteinemia (HHcy) causes hypomethylation which is an important mechanism that links Hcy to dementia ... Current evidence suggests that Hcy-lowering treatment has a positive effect for the secondary and primary prevention of stroke. HHcy is very common in patients with Parkinson disease particularly those who receive L-dopa treatment. Furthermore, a positive association has been reported between HHcy and multiple sclerosis. Moreover, HHcy and vitamin B deficiency are reported to have a causal role in depression, and epilepsy. In addition several anti-epileptic drugs cause secondary HHcy. Therefore, sufficient intakes of the vitamins are recommended for patients who have already developed neuropsychiatric diseases. Vitamin B deficiency should be suspected in children with development disorders, failure to thrive and unexplained neurological manifestations. Elderly people are also an important at-risk group where vitamin B deficiency and HHcy have been linked to neurodegenerative diseases. Treatment with folate, B (12), and B (6) can improve cerebral function. Preventive vitamin B supplementation and sufficient intake seem very important for secondary and primary prevention of neuropsychiatric disorders, especially in subjects with a low intake or status of the vitamins"
  • Plasma folate concentration and cognitive performance: Rotterdam Scan Study - Am J Clin Nutr. 2007 Sep;86(3):728-34 - "After multivariate adjustment, the mean change in test score per 1-SD increase in plasma folate was 0.05 (95% CI: 0.01, 0.09) for global cognitive function, 0.08 (95% CI: 0.04, 0.13) for psychomotor speed, and 0.02 (95% CI: -0.04, 0.07) for memory function ... The odds ratio relating a 1-SD increase in plasma folate to the presence compared with the absence of severe white matter lesions was 0.79 (95% CI: 0.66, 0.94), whereas no relation was seen between folate status and hippocampal or amygdalar volume" - See iHerb folic acid products.
  • Effect of dietary B vitamins on BMD and risk of fracture in elderly men and women: The Rotterdam Study - one. 2007 Aug 17 - "As compared to the three lowest quartiles, individuals in the highest quartile of age- and energy-adjusted dietary pyridoxine intake had a decreased risk of non-vertebral fractures (HR=0.77, 95% CI=0.65-0.92, p=0.005) and of fragility fractures (HR=0.55"
  • Folate: in vitro and in vivo effects on VLDL and LDL oxidation - Int J Vitam Nutr Res. 2007 Jan;77(1):66-72 - "folic acid supplementation reduced tHcy and protected both VLDL and LDL against oxidation. These findings provide further support for the use of folic acid supplements to aid in the prevention of atherosclerosis"
  • High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo Diet and Cancer cohort - Am J Clin Nutr. 2007 Aug;86(2):434-43 - "Compared with the lowest quintile, the incidence of invasive breast cancer was reduced in the highest quintile of dietary folate intake (HR: 0.56; 95% CI: 0.35, 0.90; P for trend = 0.02); total folate intake, including supplements (HR: 0.56; 95% CI: 0.34, 0.91; P for trend = 0.006); and dietary folate equivalents (HR: 0.59" - See iHerb folic acid products.
  • Efficacy of folic acid supplementation in stroke prevention: a meta-analysis - Lancet. 2007 Jun 2;369(9576):1876-82 - "Folic acid supplementation significantly reduced the risk of stroke by 18%"
  • Correlations between folate, B12, homocysteine levels, and radiological markers of neuropathology in elderly post-stroke patients - J Am Coll Nutr. 2007 Jun;26(3):272-8 - "folate deficiency and hyperhomocysteinemia are prevalent in elderly post-stroke patients. These two conditions are strongly and independently associated with the development of brain atrophy"
  • Blood folate levels and risk of liver damage and hepatocellular carcinoma in a prospective high-risk cohort - Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1279-82 - "When comparing persons in the lowest quartile RBC folate to persons in all other quartiles, the analysis found that higher RBC folate levels were associated with reduced risk of hepatocarcinogenesis (odds ratio, 0.33" - See iHerb folic acid products.
  • Effects of folic acid and vitamin B complex on serum C-reactive protein and albumin levels in stable hemodialysis patients - Curr Med Res Opin. 2007 Jun 29 - "Folic acid and vitamin B complex co-administration effectively lowers tHcy and hs-CRP levels and increases albumin levels in stable hemodialysis subjects, underscoring their potential benefit to attenuate the state of inflammation and possibly improve the nutritional status in patients on hemodialysis"
  • Low Intake of Vitamin B-6 Is Associated with Increased Risk of Colorectal Cancer in Japanese Men - J Nutr. 2007 Jul;137(7):1808-1814 - "We observed a significant inverse association between vitamin B-6 intake and colorectal cancer in men. Compared with the lowest quartile, the multivariate hazard ratio (95% [CI]) in the highest quartile of intake was 0.69"
  • Effect of folic Acid on endothelial function following acute myocardial infarction - Am J Cardiol. 2007 Feb 15;99(4):476-81 - "6-week treatment with high-dose folic acid improves endothelial function in post-AMI patients, independent from homocysteine status. Folic acid can be recommended to improve postinfarction endothelial dysfunction in patients with normo- and hyperhomocysteinemia"
  • Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial - Lancet. 2007 Jan 20;369(9557):208-16 - "Folic acid supplementation for 3 years significantly improved domains of cognitive function that tend to decline with age"
  • Vitamin B6 supplementation increases immune responses in critically ill patients - Eur J Clin Nutr. 2006 Oct;60(10):1207-13 - "T-lymphocyte and T-helper cell numbers and the percentage of T-suppressor cell significantly increased on day 14 in the B6 -50 group. Total lymphocyte count, T-helper and T-suppressor cell numbers, the percentage of T-lymphocyte cells and T-suppressors significantly increased in the B6 -100 group at the 14th day"
  • B-vitamins reduce plasma levels of beta amyloid - Neurobiol Aging. 2006 Nov 17 - "Elevated plasma homocysteine (tHcy) is a risk factor for Alzheimer's disease (AD), and thus B vitamins may have a role in the prevention of AD. The objective of this study was to determine if tHcy lowering vitamins decrease the circulating levels of A-beta protein 1-40 (Abeta40). We randomized 299 older men to treatment with 2mg of folate, plus 25mg of B6 and 400mug of B12, or placebo. After 2 years of treatment the mean (S.E.) increase of Abeta40 was 7.0pg/ml (8.4) in the vitamin group (4.9%), and 26.8pg/ml (7.7) (18.5%) in the placebo group. We conclude that B vitamins may decrease the plasma level of Abeta40 and have a role in the prevention of AD"
  • High- but not low-dose folic acid improves endothelial function in coronary artery disease - Eur J Clin Invest. 2006 Dec;36(12):850-9 - "Both 400 microg day(-1) and 5 mg day(-1) FA significantly increased plasma folate and decreased plasma Hcy. The FMD improved significantly after 6 weeks' treatment of 5 mg day(-1) FA but did not correlate with the reduction in Hcy. There was no change in FMD in either the 400 microg FA or placebo group"
  • Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering - Vasc Med. 2006 May;11(2):101-9 - "2 weeks of folic acid supplementation can improve endothelial dysfunction in type 2 diabetics independent of homocysteine-lowering" - See iHerb or Vitacost icon folic acid products.
  • Folate and vitamin b6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus - Pediatrics. 2006 Jul;118(1):242-53 - "High-dose folate and vitamin B(6) normalized endothelial dysfunction in children with type 1 diabetes. This effect was maintained over 8 weeks, with no additional benefit from combination treatment"
  • Loss of vision as a presenting sign of cobalamin deficiency: An eye-opener - Eur J Intern Med. 2006 Jul;17(4):292-4 - "We describe a patient who presented with loss of vision that turned out to be caused by cobalamin deficiency. Both her vision and her visual field improved upon supplementation of cobalamin. It is, therefore, important to consider cobalamin deficiency as a treatable cause of loss of vision" - Note:  Cobalamin is vitamin B12.
  • Older Adults May Need B12 Dose More Than 200 Times the RDA to Normalize Mild Vitamin Deficiency - Medscape, 5/26/06 - "As both methylmalonyl-coenzyme A (MMA) and homocysteine are metabolized by vitamin B12, elevated levels of these compounds in the plasma can reflect vitamin deficiency ... One analysis yielded 500 μg of vitamin B12 as the minimum dose necessary to produce the greatest effect on MMA levels. There was little additional benefit in using daily doses of vitamin B12 of more than 500 μg"
  • Effect of nicotinamide on newly diagnosed type 1 diabetic children - Acta Pharmacol Sin. 2006 Jun;27(6):724-7 - "even low doses of oral NA given to children with newly diagnosed type 1 diabetes may reduce insulin requirements and prolong the honeymoon period"
  • Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials - Fam Pract. 2006 Apr 3 - "The evidence derived from these limited studies suggests that 2000 microg doses of oral vitamin B12 daily and 1000 microg doses initially daily and thereafter weekly and then monthly may be as effective as intramuscular administration in obtaining short-term haematological and neurological responses in vitamin B12-deficient patients"
  • Folic acid supplementation for 3 wk reduces pulse pressure and large artery stiffness independent of MTHFR genotype - Am J Clin Nutr. 2005 Jul;82(1):26-31 - "5 mg folic acid/d ... Folic acid reduced brachial pulse pressure by 4.7 ... Folic acid is a safe and effective supplement that targets large artery stiffness and may prevent isolated systolic hypertension" - See iHerb or Vitacost icon folic acid products.
  • Reducing toxicity of methotrexate with folic acid - Z Rheumatol. 2005 Jun;64(5):353-8 - "Folate supplementation should, the